The CONFIDENCE Registry

Status Active, not recruiting

Clinical Trial Summary

The purpose of this clinical investigation is to characterize the procedural safety and device performance of transfemoral implantation of the Portico™ Transcatheter Aortic Heart Valve in patients with symptomatic degenerative aortic stenosis.

Clinical Trial Description

The CONFIDENCE registry study will be conducting as a prospective, non-randomized, observational, single-arm, multi-center study. Approximately 1000 subjects with severe symptomatic (NYHA class ≥ II) aortic stenosis (AS), will undergo Portico™ Transcatheter Aortic Heart Valve implantation. The subject data will be collected at baseline, index procedure, pre- discharge, 30 days and 12 months from the index procedure. ;

Study Design

Related Conditions & MeSH terms

Aortic Valve Stenosis
Constriction, Pathologic
Severe Aortic Stenosis
Symptomatic Degenerative Aortic Stenosis

Clinical Trial Details

NCT number	NCT03752866
Study type	Interventional
Source	Abbott Medical Devices
Contact
Status	Active, not recruiting
Phase	N/A
Start date	October 25, 2018
Completion date	December 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01238497` - SOURCE XT REGISTRY
Recruiting	`NCT04029844` - Colibri Transcatheter Aortic Heart Valve System Study	N/A
Recruiting	`NCT03280433` - Influence of EPICardial Adipose Tissue in HEART Diseases: EPICHEART Study	N/A
Completed	`NCT05492383` - SAvvyWire™ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI)	N/A
Completed	`NCT01651780` - Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH	Phase 3
Recruiting	`NCT06173115` - Comparison of a Single Versus Double Perclose Technique for TAVR	N/A
Recruiting	`NCT06136429` - A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis	N/A
Not yet recruiting	`NCT06015997` - Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR
Recruiting	`NCT03291925` - Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiography Prior to TAVI	N/A
Terminated	`NCT03004599` - Safety and Efficacy of SYM-SV/DS-002 in Patients With Severe Aortic Stenosis	N/A
Recruiting	`NCT04076150` - Safety and Performance Study of the Optimum Transcatheter Aortic Valve	N/A
Completed	`NCT01074658` - CoreValve Advance International Post Market Study	N/A
Completed	`NCT02575768` - Myocardial Flow Reserve in Severe AS Without Obstructive Coronary Artery Disease	N/A
Completed	`NCT01994330` - Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery	Phase 4
Completed	`NCT04286893` - Improved HRV, Inflammation Markers and Endothelial Function After TAVI
Not yet recruiting	`NCT06177392` - VARC-TAVI VALVE IMPLANTATION)	N/A
Active, not recruiting	`NCT04206228` - Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis	Phase 2
Not yet recruiting	`NCT03788590` - Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System	N/A
Completed	`NCT01531374` - Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement	N/A
Recruiting	`NCT05493657` - Aspirin vs Clopidogrel After TAVR	N/A